Cargando…
Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies
BACKGROUND: COVID-19 has stroke Brazil harshly, deaths by COVID-19 in Brazil represent almost 13% of the total deaths by COVID-19 in the world, even though Brazilian population represents only 2.6% of the world population. Our aim in this study was to evaluate death and intubation outcomes and risk...
Autores principales: | Tamura, Rodrigo Esaki, Said, Said Muhammad, de Freitas, Leticia Mussin, Rubio, Ileana Gabriela Sanchez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275913/ https://www.ncbi.nlm.nih.gov/pubmed/34256824 http://dx.doi.org/10.1186/s13098-021-00695-8 |
Ejemplares similares
-
Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
por: Morale, Mirian Galliote, et al.
Publicado: (2022) -
The use of adenoviral vectors in gene therapy and vaccine
approaches
por: Araújo, Natália Meneses, et al.
Publicado: (2022) -
Metformin Improves Biochemical and Pathophysiological Changes in Hepatocellular Carcinoma with Pre-Existed Diabetes Mellitus Rats
por: Mobasher, Maysa A., et al.
Publicado: (2021) -
Do pre-hospital poisoning deaths differ from in-hospital deaths? A retrospective analysis
por: Koskela, Lauri, et al.
Publicado: (2017) -
Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19
por: Li, Jinghong, et al.
Publicado: (2020)